Kamada Ltd. Reports 2016 First Quarter Financial Results

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces financial results for the three months ended March 31, 2016.

Financial highlights of the 2016 first quarter included: • Total revenues of $14.8 million compared with $8.9 million in the 2015 first quarter

Back to news